Elsa Curtit
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 6
- Cancer survivorship and care 5
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 6
- Co-authors
- Xavier Pivot (25 shared papers)Virginie Nerich (8 shared papers)L. Chaigneau (17 shared papers)Laura Mansi (12 shared papers)Fernando Bazán (13 shared papers)Cristian Villanueva (8 shared papers)Antoine Thiery-Vuillemin (10 shared papers)Thierry Nguyen (7 shared papers)
- Journals
- Annals of Oncology (5 papers)BMC Cancer (3 papers)Journal of Clinical Oncology (2 papers)Medical Oncology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Elsa Curtit
44 papers receiving 450 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 87
- Hepatology 43
- Oncology 147
- Genetics 36
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Elsa Curtit
This map shows the geographic impact of Elsa Curtit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Curtit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Curtit more than expected).
Fields of papers citing papers by Elsa Curtit
This network shows the impact of papers produced by Elsa Curtit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Curtit. The network helps show where Elsa Curtit may publish in the future.
Co-authors
The 25 scholars most cited alongside Elsa Curtit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 74 | |
| 2 | 2019 | 53 | |
| 3 | 2011 | 41 | |
| 4 | 2016 | 33 | |
| 5 | 2022 | 19 | |
| 6 | 2016 | 18 | |
| 7 | 2013 | 17 | |
| 8 | 2019 | 17 | |
| 9 | 2019 | 15 | |
| 10 | 2012 | 15 | |
| 11 | 2019 | 13 | |
| 12 | 2017 | 10 | |
| 13 | 2011 | 10 | |
| 14 | 2011 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2015 | 7 | |
| 18 | 2016 | 7 | |
| 19 | 2019 | 7 | |
| 20 | Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury. | 2012 | 7 |
About Elsa Curtit
Elsa Curtit is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 47 papers that have together received 457 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (6 papers), Cancer survivorship and care (5 papers), Glioma Diagnosis and Treatment (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Cancer Research (87 citations), Hepatology (43 citations), Oncology (147 citations), Genetics (36 citations) and Pulmonary and Respiratory Medicine (75 citations). Elsa Curtit has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Xavier Pivot, Virginie Nerich, L. Chaigneau, Laura Mansi, Fernando Bazán, Cristian Villanueva, Antoine Thiery-Vuillemin, Thierry Nguyen, Philippe Montcuquet and Erion Dobi. Their work appears in journals such as Annals of Oncology, BMC Cancer, Journal of Clinical Oncology, Medical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.